Australia's most trusted
source of pharma news
Wednesday, 17 December 2025
Posted 16 December 2025 AM
2026 has been branded the Year of Disruption with the difference between growth and decline resting on the shoulders of local leaders who are working in an increasingly challenging ANZ market.
Pharma in Focus asked country bosses what was on their New Year wish list and faster, fairer access to medicines for Australian patients was a clear winner. But there is an urgency for delivery of meaningful HTA Reform in 2026 that is far more pressing than in previous years.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.